Gamco Investors INC. ET AL Increases Holdings in Integer Holdings Corp (NYSE:ITGR)

Gamco Investors INC. ET AL grew its position in shares of Integer Holdings Corp (NYSE:ITGR) by 18.0% in the third quarter, according to its most recent filing with the SEC. The fund owned 32,131 shares of the medical equipment provider’s stock after acquiring an additional 4,900 shares during the quarter. Gamco Investors INC. ET AL owned about 0.10% of Integer worth $2,428,000 at the end of the most recent reporting period.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. BlackRock Inc. raised its holdings in Integer by 2.8% during the 2nd quarter. BlackRock Inc. now owns 4,892,982 shares of the medical equipment provider’s stock valued at $410,619,000 after buying an additional 133,532 shares during the period. Vanguard Group Inc. raised its holdings in Integer by 3.0% during the 2nd quarter. Vanguard Group Inc. now owns 3,924,329 shares of the medical equipment provider’s stock valued at $329,329,000 after buying an additional 114,503 shares during the period. Silvercrest Asset Management Group LLC raised its holdings in Integer by 22.4% during the 2nd quarter. Silvercrest Asset Management Group LLC now owns 943,985 shares of the medical equipment provider’s stock valued at $79,219,000 after buying an additional 172,758 shares during the period. Northern Trust Corp raised its holdings in Integer by 6.3% during the 2nd quarter. Northern Trust Corp now owns 854,642 shares of the medical equipment provider’s stock valued at $71,723,000 after buying an additional 51,001 shares during the period. Finally, Nuveen Asset Management LLC raised its holdings in Integer by 12,967.5% during the 2nd quarter. Nuveen Asset Management LLC now owns 700,546 shares of the medical equipment provider’s stock valued at $58,790,000 after buying an additional 695,185 shares during the period. Hedge funds and other institutional investors own 99.39% of the company’s stock.

In other Integer news, Director Pamela G. Bailey sold 7,446 shares of the stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $76.75, for a total value of $571,480.50. Following the sale, the director now owns 56,990 shares in the company, valued at $4,373,982.50. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Company insiders own 2.24% of the company’s stock.

ITGR stock traded up $0.77 during midday trading on Friday, reaching $74.76. The company’s stock had a trading volume of 166,168 shares, compared to its average volume of 203,012. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.35 and a current ratio of 2.40. The stock has a fifty day simple moving average of $75.05 and a two-hundred day simple moving average of $76.87. Integer Holdings Corp has a 1 year low of $67.72 and a 1 year high of $92.61. The firm has a market capitalization of $2.42 billion, a price-to-earnings ratio of 19.67 and a beta of 1.02.

Integer (NYSE:ITGR) last released its earnings results on Thursday, October 31st. The medical equipment provider reported $1.20 earnings per share for the quarter, topping analysts’ consensus estimates of $1.06 by $0.14. Integer had a return on equity of 13.47% and a net margin of 8.99%. The business had revenue of $303.59 million for the quarter, compared to analyst estimates of $313.78 million. During the same quarter last year, the firm posted $1.06 earnings per share. The business’s revenue was down .5% compared to the same quarter last year. As a group, analysts forecast that Integer Holdings Corp will post 4.62 EPS for the current fiscal year.

ITGR has been the topic of several recent research reports. Northcoast Research restated a “buy” rating on shares of Integer in a report on Friday, August 2nd. ValuEngine lowered Integer from a “hold” rating to a “sell” rating in a report on Friday, August 2nd. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and one has given a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus target price of $65.76.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer worldwide. It operates in two segments, Medical and Non-Medical. The company offers products for vascular, cardiac surgery, and structural heart diseases; peripheral vascular, neurovascular, urology, and oncology products; and electrophysiology, infusion therapy, and hemodialysis products.

Further Reading: What is the Book Value of a Share?

Institutional Ownership by Quarter for Integer (NYSE:ITGR)

Leave a Reply

Your email address will not be published. Required fields are marked *